Warning: This security is no longer trading.
defunct
Stemline Therapeutics, Inc. (STML): Price and Financial Metrics
STML Price/Volume Stats
| Current price | $11.83 | 52-week high | $18.22 |
| Prev. close | $12.00 | 52-week low | $3.21 |
| Day low | $11.82 | Volume | 17,354,300 |
| Day high | $12.10 | Avg. volume | 1,524,566 |
| 50-day MA | $8.63 | Dividend yield | N/A |
| 200-day MA | $8.77 | Market Cap | 621.21M |
STML Stock Price Chart Interactive Chart >
Stemline Therapeutics, Inc. (STML) Company Bio
Stemline Therapeutics is a clinical stage biopharmaceutical company developing novel therapeutics that target cancer stem cells (CSCs) and tumor bulk. The company was founded in 2003 and is based in New York, New York.
STML Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 9.23% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 11.89% |
Continue Researching STML
Here are a few links from around the web to help you further your research on Stemline Therapeutics Inc's stock as an investment opportunity:Stemline Therapeutics Inc (STML) Stock Price | Nasdaq
Stemline Therapeutics Inc (STML) Stock Quote, History and News - Yahoo Finance
Stemline Therapeutics Inc (STML) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...